Cargando…
Economic evaluation of bailing capsules for patients with diabetic nephropathy in China
Background: Diabetic nephropathy is a major microvascular complication and the main cause of end-stage renal disease in diabetic patients. The therapeutic effects of Bailing capsules for diabetic nephropathy have already been demonstrated; however, the cost-effectiveness of Bailing capsules remains...
Autores principales: | He, Yumei, Li, Wei, Zhu, He, Han, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354420/ https://www.ncbi.nlm.nih.gov/pubmed/37475712 http://dx.doi.org/10.3389/fphar.2023.1175310 |
Ejemplares similares
-
Effects of Bailing capsule on diabetic nephropathy based on UPLC-MS urine metabolomics
por: Xu, Junnan, et al.
Publicado: (2019) -
Bailing capsule (Cordyceps sinensis) ameliorates renal triglyceride accumulation through the PPARα pathway in diabetic rats
por: Zhang, Qian, et al.
Publicado: (2022) -
Economic evaluation of tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
por: Shi, Fenghao, et al.
Publicado: (2022) -
Clinical and Economic Evaluation of Salvianolate Injection for Coronary Heart Disease: A Retrospective Study Based on National Health Insurance Data in China
por: Yang, Lisong, et al.
Publicado: (2020) -
San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism
por: Su, Xiuhai, et al.
Publicado: (2022)